HomeTagsNanoViricides Inc

Tag: NanoViricides Inc

spot_imgspot_img

NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun

NanoViricides, Inc. (NYSE American:NNVC) (the Company) reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img